TG THERAPEUTICS, INC. Shareholders' Equity
TG THERAPEUTICS, INC. (TGTX) had Shareholders' Equity of $604.08 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-05
- 2026-06-30: Stockholders' Equity Attributable to Parent $604.08M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $583.13M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $648.02M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $607.22M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $604.08M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $583.13M 10-Q · filed 2026-08-05 |
| 2025-12-31 | $648.02M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $607.22M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $276.43M 10-Q · filed 2026-08-05 |
| 2025-03-31 | $237.29M 10-Q · filed 2026-08-05 |
| 2024-12-31 | $222.36M 10-Q · filed 2026-08-05 |
| 2024-09-30 | $192.16M 10-Q · filed 2025-11-05 |
| 2024-06-30 | $177.57M 10-Q · filed 2025-11-05 |
| 2024-03-31 | $160.11M 10-Q · filed 2025-11-05 |
| 2023-12-31 | $160.50M 10-K · filed 2026-02-27 |
| 2023-09-30 | $164.77M 10-Q · filed 2024-11-07 |
| 2023-06-30 | $40.45M 10-Q · filed 2024-11-07 |
| 2023-03-31 | $27.43M 10-Q · filed 2024-11-07 |
| 2022-12-31 | $58.59M 10-K · filed 2026-02-27 |
| 2022-09-30 | $100.48M 10-Q · filed 2023-11-06 |
| 2022-06-30 | $129.03M 10-Q · filed 2023-11-06 |
| 2022-03-31 | $170.39M 10-Q · filed 2023-11-06 |
| 2021-12-31 | $237.15M 10-K · filed 2025-03-03 |
| 2020-12-31 | $519.35M 10-K · filed 2024-02-29 |
| 2012-12-31 | $15.55M 10-K · filed 2013-03-21 |
| 2012-09-30 | $9.37M 10-Q · filed 2012-11-14 |
| 2012-06-30 | $11.02M 10-Q/A · filed 2012-09-07 |
| 2012-03-31 | $11.74M 10-Q · filed 2012-05-14 |
| 2011-12-31 | $9.62M 10-K · filed 2013-03-21 |
| 2011-09-30 | -$294.62K 10-Q · filed 2011-11-14 |
| 2011-06-30 | -$2.15M 10-Q/A · filed 2011-09-14 |
| 2010-12-31 | -$5.36M 10-Q · filed 2011-11-14 |
| 2009-12-31 | -$6.78M 10-Q · filed 2011-11-14 |
| 2008-12-31 | -$4.38M 10-Q · filed 2011-11-14 |
| 2007-12-31 | -$891.09K 10-Q · filed 2011-11-14 |
| 2006-12-31 | $1.50M 10-Q · filed 2011-11-14 |
| 2005-12-31 | $9.54M 10-Q · filed 2011-11-14 |
| 2004-12-31 | $4.15M 10-Q · filed 2011-11-14 |
| 2003-12-31 | $6.83M 10-Q · filed 2011-11-14 |
| 2002-12-31 | $637.92K 10-Q · filed 2011-11-14 |
| 2001-12-31 | -$56.80K 10-Q · filed 2011-11-14 |
| 2000-12-31 | $0.00 10-Q · filed 2011-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |